IPO Trending
HAMPSSME / BSEListed

Hamps Bio Limited

Hamps Bio Limited, incorporated in 2007, is engaged in marketing and distributing pharmaceutical products under the “Hamps” brand and freeze-dried and frozen FMCG items under the “FzyEzy” brand. Its pharmaceutical portfolio includes tablets, syrups, capsules, injectables, and powders, distributed across eight Indian states and union territories through 50+ distributors and online platforms such as Amazon, Flipkart, and Jio Mart. The company’s FMCG division offers freeze-dried and frozen products like strawberry, mango, and beet powders for both B2B and B2C markets, including contract manufacturing. With a portfolio of 180+ products across both verticals, Hamps Bio serves domestic and international markets and employed 78 people as of October 31, 2024.

₹51 - ₹511050.21x sub
Listed Price96.90
Listing Gain+90.00%
Review-Analyst Consensus Verdict

May apply

No review summary is available yet.

Apply
00%
May Apply
00%
Neutral
00%
Avoid
00%
Not Rated
00%
No IPO review records are available for this issue yet.